Name:
Introduction to the Restoring Vision Through Regeneration Special Issue and AOPT Meeting
Description:
Introduction to the Restoring Vision Through Regeneration Special Issue and AOPT Meeting
Thumbnail URL:
https://cadmoremediastorage.blob.core.windows.net/b8ebdf00-0fd3-407a-a8b1-f6f22f5bfaa4/videoscrubberimages/Scrubber_0.jpg?sv=2019-02-02&sr=c&sig=nAzP2JMFW0VL6jCfcgGbKSv7sCTo6nLu7QvfAfphjGg%3D&st=2024-04-27T09%3A46%3A10Z&se=2024-04-27T13%3A51%3A10Z&sp=r
Duration:
T00H03M10S
Embed URL:
https://stream.cadmore.media/player/b8ebdf00-0fd3-407a-a8b1-f6f22f5bfaa4
Content URL:
https://cadmoreoriginalmedia.blob.core.windows.net/b8ebdf00-0fd3-407a-a8b1-f6f22f5bfaa4/MVI_1199.MP4?sv=2019-02-02&sr=c&sig=jHb2jGbunXWEVFx2iACRaIZTsh6u%2FXSqb2nSxXjfKxo%3D&st=2024-04-27T09%3A46%3A10Z&se=2024-04-27T11%3A51%3A10Z&sp=r
Upload Date:
2023-11-06T00:00:00.0000000
Transcript:
Language: EN.
Segment:0 .
SPEAKER 1: All right, recording. Go ahead.
SPEAKER 2: Dr. Hackam, thank you very much for speaking with me today. I wanted to ask you how axonal regeneration became a theme for the 2021 AOPT meeting and how that inspired this current issue on vision and visual restoration in JOPT.
ABIGAIL HACKAM: Right. So as you know, I was an organizer and co-PI for the NIH R13 grant that supported the AOPT 2021 meeting. So we brainstormed, and we arrived at the theme of restoring vision through regeneration. As you know, axonal regeneration is a huge topic of work and really promising for therapeutic purposes. And there's many individuals here and many investigators at Bascom Palmer and in Miami working on the topic.
ABIGAIL HACKAM: So although COVID was a challenge, it allowed it to expand invitations, invite more people in the field working on the topic, including Dr. Zhigang He and Larry Benowitz. In fact, Dr. He provided an editorial in the special issue in the JOPT.
SPEAKER 2: Wonderful. So what topic outside of axonal regeneration will be included in the special issue at GOPT?
ABIGAIL HACKAM: So the special issue was designed to appeal to a broad range of investigators in the vision community. So in addition to axonal regeneration, it includes articles on corneal regeneration, dietary interventions, electromagnetic therapy, and so on. In fact, we also have articles from Dr. Pinchuk and Hirani on enterprise formation and other regulatory affairs that would be of interest to the community.
SPEAKER 2: Wonderful.
ABIGAIL HACKAM: So perhaps you could tell me a little bit about the AOPT meeting that you went to this year.
SPEAKER 2: Sure. I had the wonderful opportunity to be awarded the NIH Travel Fellowship grant to be able to attend the AOPT meeting in Indianapolis this year. I thought it was a wonderful conference that was comprised of many of the translational researchers that I had read their papers and had some background knowledge on. And it was kind of like meeting my heroes at this conference. So I thought it was a wonderful, wonderful opportunity to basically learn not only about what axonal regeneration progress has been made in the murine model, which is my focus, but also to learn about other translational models, invertebrates, things like this, and to basically get an opportunity to get the sage advice of different molecular techniques and more specific protocols which I've been given this access to by attending this conference.
SPEAKER 2: So I thought it was a wonderful opportunity to basically learn, in the translational realm, a little bit outside of direct clinical medicine, what's going on in the field, what progress has been made, and has been a great lesson to myself that I've taken knowledge from, to practice and to implement at this laboratory in Bascom Palmer. So I had a great opportunity. And I think that it's also a great conference that if we can galvanize medical students such as myself or other PhD or master's students to be inspired to attend in 2025 to apply for this NIH Travel Fellowship, to present their work and to have, again, a great opportunity to learn, as I have.
ABIGAIL HACKAM: Fantastic. Wonderful. Well, thank you very much. It's been a pleasure discussing this with you.
SPEAKER 2: Thank you very much, Dr. Hackam.